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While many data on molecular epidemiology of MRSA are available for North America, Western 
Europe and Australia, much less is known on the distribution of MRSA clones elsewhere. Here, we 
describe a poorly known lineage from the Middle East, CC1153, to which several strains from humans 
and livestock belong. Isolates were characterised using DNA microarrays and one isolate from the 
United Arab Emirates was sequenced using Nanopore technology. CC1153 carries agr II and capsule 
type 5 genes. Enterotoxin genes are rarely present, but PVL is common. Associated spa types include 
t504, t903 and t13507. PVL‑positive CC1153‑MSSA were found in Egyptian cattle suffering from 
mastitis. It was also identified among humans with skin and soft tissue infections in Saudi Arabia, 
France and Germany. CC1153‑MRSA were mainly observed in Arabian Gulf countries. Some isolates 
presented with a previously unknown SCCmec/SCCfus chimeric element in which a mec B complex 
was found together with the fusidic acid resistance gene fusC and accompanying genes including 
ccrA/B-1 recombinase genes. Other isolates carried SCCmec V elements that usually also included 
fusC. Distribution and emergence of CC1153‑MRSA show the necessity of molecular characterization 
of MRSA that are resistant to fusidic acid. These strains pose a public health threat as they combine 
resistance to beta‑lactams used in hospitals as well as to fusidic acid used in the community. Because 
of the high prevalence of fusC‑positive MRSA in the Middle East, sequences and descriptions of SCC 
elements harbouring fusC and/or mecA are reviewed. When comparing fusC and its surrounding 
regions from the CC1153 strain to available published sequences, it became obvious that there are 
four fusC alleles and five distinct types of fusC gene complexes reminiscent to the mec complexes in 
SCCmec elements. Likewise, they are associated with different sets of ccrA/B recombinase genes and 
additional payload that might include entire mec complexes or SCCmec elements.
OPEN
1Leibniz Institute of Photonic Technology (IPHT), Jena, Germany. 2InfectoGnostics Research Campus Jena, Jena, 
Germany. 3Institute for Medical Microbiology and Hygiene, Medical Faculty “Carl Gustav Carus”, Technische 
Universität Dresden, Dresden, Germany. 4Institute for Clinical Chemistry and Laboratory Medicine, Municipal 
Hospital Dresden, Dresden, Germany. 5Centre National de Référence des Staphylocoques, Institut des Agents 
Infectieux, Hospices Civils de Lyon, Lyon, France. 6Department of Microbiology, Faculty of Medicine, Kuwait 
University, Jabriya, Kuwait. 7Department of Internal Medicine and Infectious Diseases, Faculty of Veterinary 
Medicine, Mansoura University, Mansoura, Egypt. 8BLINK AG, Jena, Germany. 9PTC-Phage Technology Center 
GmbH, Bönen, Germany. 10Department of Hygiene and Zoonoses, Faculty of Veterinary Medicine, Mansoura 
University, Mansoura, Egypt. 11Formerly Friedrich-Loeffler-Institut (Federal Research Institute for Animal Health), 
Institute of Bacterial Infections and Zoonoses, Jena, Germany. 12College of Medicine, Mohammed Bin Rashid 
University of Medicine and Health Sciences, Dubai, United Arab Emirates. 13Oral and Biomedical Sciences, School 
of Dentistry, Cardiff University, Cardiff, UK. 14Department of Pathology and Laboratory Medicine, College of 
Medicine, King Saud University Medical City and King Saud University, Riyadh, Saudi Arabia. 15Institute of Physical 
Chemistry, Friedrich Schiller University, Jena, Germany. *email: stefan.monecke@leibniz-ipht.de
2
Vol:.(1234567890)
Scientific Reports |         (2021) 11:8128  | https://doi.org/10.1038/s41598-021-86273-4
www.nature.com/scientificreports/
Staphylococcus aureus (S. aureus) is a common coloniser, or pathogen, among humans as well as among wild 
and domestic animals. It can cause a broad variety of infections that include not only superficial skin and soft 
tissue infections (SSTI) but also life-threatening conditions such as sepsis, infective endocarditis and pneumonia. 
While beta-lactams are crucial for treatment, resistant strains, so-called methicillin-resistant Staphylococcus 
aureus (MRSA), were first reported nearly 60 years  ago1. Beta-lactam resistance in MRSA is caused by alterna-
tive penicillin-binding proteins encoded by different mec genes/alleles, out of which mecA is the most common 
and widespread  one2, 3. The mecA gene is located on large and complex genetic elements, known as SCCmec 
(“staphylococcal cassette chromosome” or “staphylococcal chromosomal cassette” harbouring mecA) in which 
it is linked to ccr recombinase genes and, variably, to additional genes encoding antimicrobial or heavy metal 
 resistance4–11. Originally, MRSA was restricted to healthcare settings, but from the mid-1990s on, infections with 
community-acquired MRSA (CA-MRSA) were observed. Many, but not all, CA-MRSA strains carry emerging 
SCCmec types IV or V, as well as Panton-Valentine leukocidin (PVL; encoded by lukS/F-PV genes). This is a 
cytotoxic, pore forming toxin localized on prophages. It is associated with recurrent, chronic and/or severe 
SSTI as well as with rapidly progressing necrotising pneumonia. The emergence and spread of PVL-positive 
CA-MRSA has extensively been studied in the United States and Australia, where they are common, as well as 
in Western Europe, where they pose a comparatively minor problem. Less data is available for other parts of the 
world, but during recent years it became obvious that PVL-positive CA-MRSA are an important public health 
issue in Mediterranean countries, the greater Middle East, Pakistan and India. The Arabian Gulf countries are 
of special interest because they are a major destination for migrants, expatriate workers, tourists and pilgrims 
from all over the world. This might result in importation, exchange and exportation of MRSA strains epidemic 
to other regions of the world. Indeed, in these countries, a high degree of diversity of MRSA strains has been 
observed with several strains being linked to other parts of the  world12–15.
Since PVL is associated with clinically relevant skin conditions, topical treatments are frequently used. One 
option is fusidic acid, a steroid antibiotic known since the 1960s. Unfortunately, an excessive consumption of 
fusidic acid might quickly lead to an emergence of resistance, as it is well documented from New  Zealand16, 17. 
Fusidic acid resistance is common in Middle Eastern/Arabian Gulf states, usually being due to plasmid-borne 
fusB/far113, 18–24 or SCC-associated fusC12, 25–32.
Here, we describe a poorly known S. aureus lineage from the Middle East, CC1153, to which several distinct 
strains from humans and from livestock belong. Most isolates identified are PVL-positive, and many are MRSA 
that additionally harbour fusC. One CC1153 strain harboured a previously undescribed SCCmec/fus composite 
element. This observation prompted Nanopore sequencing and subsequent analysis of its genome. SCCmec/fus 
are reviewed and five distinct gene clusters associated with fusC are defined.
Results
Description of the clonal complex. CC1153 included sequence types (ST) 1153 (1–13–1–1–124–5–3) 
and ST2482 (1–141–1–1–124–8–3). Possible RIDOM spa types are t504 (26–17–20–17–12), t903 (26–22–19–
17–17–20–17–12) and t13507 (26–22–19–17–17–20–17). Isolates belonged to agr group II and capsule type 5. 
The sasG gene was present but cna and the enterotoxin homologue ORF CM14 are uniformly absent. CC1153 
isolates did not harbour egc locus and leukocidin genes lukD/E were variably present.
When analysing 154 core genomic markers (Supplement 3), CC1153 appeared to be most related to CC6, 
CC7 and CC1290. When comparing these 154 markers, all together consisting of 124.248 nucleotides, to CC6 
strain PFESA1528, (GenBank FKTB), CC7 strain TCH959 (GenBank AASB) and CC1290 strain 015H (Gen-
Bank FMMV), differences of respectively, 0.38%, 0.37% and 0.38% were noted. As comparison, for CC1 (MW2, 
BA000033), CC5 (N315, BA000018), CC8 (TCH1516, CP000730) and S. argenteus CC1850 (MSHR1132, 
FR821777) differences were 0.45%, 0.51%, 0.40%, and 9.18%, respectively. However, in comparison to CC6, 
CC7 and CC1290, different agr groups (agr II in CC1153, agr group I in the others) and capsule types (cap 5 in 
CC1153, cap 8 in the others) as well as presence of cna in CC6 and absence of sasG from CC7 were noted. As 
these divergent loci are localised at distant positions across the genome, an emergence of CC1153 from these 
lineages by a single replacement of a fragment of chromosomal DNA appears to be unlikely.
CC1153‑MSSA strains. Twenty-three isolates of CC1153-MSSA were characterised (see Supplemental File 
1). They originated from France (11/23), Egypt (6/23), Saudi Arabia (5/23) and Germany (1/23). The Egyptian 
isolates originated from cattle with subclinical mastitis, all other isolates were of human origin. CC1153-MSSA 
isolates, including those from cattle, are usually PVL-positive with lukF/S-PV being detected in 21 out of 23 
isolates. Some isolates, mainly Saudi Arabian (n = 4) and French (n = 3) ones, harboured enterotoxin genes sek 
and seq. The staphylokinase gene sak and scn (staphylococcal complement inhibitor) were always present while 
only one isolate was positive for chp (chemotaxis-inhibiting protein). All isolates carried the penicillinase operon 
(blaZ/blaI/blaR) while other resistance genes were only sporadically found (erm(C), msr(A), mph(C), aadD and 
fusB/far1; each once in 23 isolates).
CC1153‑MRSA strains. Twenty-six isolates of CC1153-MRSA were identified and characterised (see Sup-
plemental File 1).
Nine isolates were assigned to different variants of SCCmec V or VT elements. Five of these isolates came from 
Kuwait, one from Riyadh, Saudi Arabia, and two from the UAE (one each from Dubai and Umm-al-Quwain) and 
one from an Egyptian child living in Germany. All isolates, except the oldest one (isolated in  200933) also carried the 
fusC gene. In two isolates, the SCCmec/fusC composite element was further characterised using a second  microarray9 
assigning them to SCCmec V + fusC (rather than to SCCmec VT + fusC). One isolate (from Kuwait) yielded the same 
pattern (with signals for mecA, ugpQ, fusC, mvaS-SCC, Q4LAG7, ccrAA, ccrC, SCCterm3, SCCterm10) as observed 
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in a possibly livestock–(i.e., camel-) associated CC15 strain from Saudi  Arabia28, 34. The other one (from Germany/
Egypt) yielded signals for mecA, ugpQ, fusC, mvaS-SCC, Q4LAG7, ccrAA, ccrC and SCCterm11 possibly indicating 
a difference affecting the SCCmec/orfX junction site and/or another SCCmec/fus subtype. Seven of these isolates 
harboured PVL genes. Enterotoxin genes and chp were not identified, but sak and scn were always present. Eight out 
of the nine isolates harboured fusC. All were positive for blaZ/blaI/blaR. The gentamicin resistance gene aacA-aphD 
was found in eight isolates, the tetracycline resistance marker tet(K) in four isolates.
Seventeen CC1153-MRSA isolates belonged to a strain which, to the best of our knowledge, carried an 
unknown SCCmec/fusC chimeric element. Three of these isolates were investigated with the second array yield-
ing signals with mecA, ugpQ, Delta mecR1, fusC, Q4LAG7 (MSSA476), mvaS-SCC, ccrA-1, ccrB-1 and dcs. This 
prompted genome sequencing of one isolate, henceforth designated M58 (see below). Isolates with the new 
chimeric element originated from Kuwait (n = 14), UAE (n = 2) and France (n = 1). All but one were positive for 
lukF/S-PV genes. Genes sak and scn were always present while enterotoxin genes were not detectable. Sixteen 
isolates of this strain harboured blaZ/blaI/blaR, and erm(C) was found once.
Description of the SCCmec element in M58. One of the seventeen isolates with an apparent unknown 
SCCmec/fusC chimeric element was subjected to genome sequencing (Nanopore) to characterise this element 
(see GenBank CP065857.1). Its gene content of the SCCmec/fusC element is summarised in Table 1, and Fig. 1 
provides a graphical overview as well as a comparison to other, previously published, reference sequences.
In short, the element comprised a mec complex B, ccrA/B-1 recombinase genes and fusC, while tirS (that com-
monly accompanies fusC35) was absent. The gene pls-SCC, which normally is part of SCCmec I, was also absent. 
This constellation raises the question whether the element was derived from a SCCmec I element truncated by 
an insertion of fusC, or if it was a mec complex B element from a SCCmec I or IV element supplemented by fusC 
and accompanying ccrA/B-1 recombinase genes.
The actual mecA allele was identical to one which is widespread in SCCmec IV strains including, for instance, 
 MW22 but differing from the one in COL. The mec complex B was followed by some genes encoding “putative 
proteins” and by ccrB-1 and ccrA-1 recombinase genes, as it was also the case in SCCmec I. A closer inspection of 
the sequence of the genes encoding “putative proteins” and of ccrB-1 revealed differences compared to the cor-
responding sequences in SCCmec I. The ccrB-1 allele from SCCmec I in COL differed by 7.2% of its nucleotides 
while ccrA-1 was too conserved to allow a meaningful analysis.
This prompted a search for possible donors of recombinase and fusC-associated genes. While fusC itself was 
identical to MSSA Sanger 476, GenBank BX571857.1, the surrounding region was different in both gene content 
(most notably, in absence of tirS) as well as in gene sequences (8.4% difference in ccrB-1). Most closely related 
sequences of fusC-associated genes were identified in the S. aureus CC5 strain 06BA18369, GenBank ARXY, and in 
the Staphylococcus hominis subsp. hominis strain NTUH-3390, GenBank KY643657.1. These strains carry Q8CU82, 
tarF-SCC, A9UFT0, Q9KX75, Q7A207, Q7A206, ccrB-1, ccrA-1, cch-1, DUF1413, Q83ZD5, helicase M06, Q6GD51, 
D3QFP0-scc, D3JCW9, fusC, tnpIS150, tnp_A8YYY6, Q4LAG7-SCCfus and yobV (for explanations and GenBank 
entries of the genes discussed, see Table 1 and Supplemental File 4). However, Q8CU82, tarF-SCC-1 and A9UFT0 
were absent in M58. The gene encoding the putative protein Q9KX75 in M58 was virtually identical to the ones in 
COL and MW2 but differed from the one in 06BA18369 and NTUH-3390, GenBank KY643657.1. From Q9KX75 
on downstream, however, 06BA18369 and NTUH-3390 sequences were virtually identical to the ones in M58.
The PVL prophage in M58. The sequence of the PVL prophage in the genome of M58 (CP065857.1) was 
identical to the one in the S. aureus CC1153 strain 3688STDY6124889, GenBank FQHT01000001.1. It was also 
identical to the PVL prophage in USA300-TCH1516, CP000730.1.
M58 was shown by a lateral flow assay to secrete detectable amounts of PVL. This was also the case for two 
other CC1153-MRSA-PseudoSCCmec [class B + fus + ccrAB1] isolates as well as for three of the CC1153-MSSA 
isolates.
Discussion
CC1153 and the SCCmec/fusC element in isolate M58. We describe a clonal complex of S. aureus 
that we identified in several Middle Eastern countries. A couple of publicly available genomes, deposited in 
GenBank (GenBank FQHT01000000) and/or the Short Read Archive (SAMEA2661948, SAMEA2661956, 
SAMEA2662240, SAMEA2662319, SAMEA2710354, SAMEA2710468, SAMEA3214613, SAMEA3448866, 
SAMEA3448996, SAMEA4547522, SAMN03289718) belong to it, but to the best of our knowledge, this 
clonal complex has not yet been reviewed. Three of these sequences originated from Thailand (GenBank 
FQHT01000000.1 as well as BioSamples SAMEA3448866 and SAMEA3448996), and one from the United King-
dom (SAMN03289718) while for the others, no locations were reported. An additional observation of CC1153 
isolates originated from  Myanmar36. Our isolates were collected in the greater Middle East (Egypt and Arabian 
Gulf countries) and Western Europe although at least one of the European cases had connections to Egypt. There 
are no data confirming or explaining a discontinuous distribution in the Middle East and in South-East Asia. 
However, the presence of millions of expatriate South-East Asians in the Gulf countries could easily explain a 
transmission of a S. aureus lineage into either direction.
An interesting observation is the presence of CC1153 in Egyptian  bovines37. The detection of PVL (rather than 
of lukM/lukF-P83) and of haemolysin-beta-converting prophages in these isolates indicates a human provenance 
of these isolates so that the cattle probably served as sentinels for an unrecognised epidemiological situation 
among humans in the Nile Delta.
The majority of CC1153, including MRSA and MSSA, is PVL-positive harbouring the same prophage (in 
M58 and FQHT01000001.1) as other pandemic strains such as USA300.
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Gene ID Explanation Position in SCC (nt) Position in genome (nt) Length (nt) Direction Sequence identical to
orfX (23S rRNA methyltransferase) 33,698–34,177 480 Forward
sRNA6 (Antisense RNA associated with orfX) 33,878–34,161 284
DR_SCC Direct repeat of SCC 1–19 34,159–34,177 19
dcs-L1 Downstream constant segment, locus 1 20–301 34,178–34,459 282 MW2, BA000033 [34169:34450]
Q9XB68-dcs Putative protein 302–1596 34,460–35,754 1295 Forward Strain 21172, AFEF01000013 [388744:390039]
Q7A213 Putative protein 2011–2250 36,169–36,408 240 Forward
COL, CP000046 [36082:36321]) 
and MW2, BA000033 
[36161:36400])
IR_IS431 Inverted repeat of IS431 2223–2238 36,381–36,396 16
COL, CP000046 [36294:36309] 
and MW2, BA000033 
[36373:36388]
tnpIS431 Transposase for IS431 2282–2956 36,440–37,114 675 Reverse (trunc.) COL, CP000046 [36353:37027]
Teg143 Trans-encoded RNA associated with tnpIS431 2987–3020 37,145–37,178 34
COL, CP000046 [37058:37091] 
and MW2, BA000033 
[37137:37170]
IR_IS431 Inverted repeat of IS431 2997–3012 37,155–37,170 16
COL, CP000046 [37058:37091] 
and MW2, BA000033 
[37137:37170]
mvaS-SCC Truncated 3-hydroxy-3-methyl-glutaryl CoA synthase 3029–3381 37,187–37,539 353 Forward
COL, CP000046 [37100:37452] 
and MW2, BA000033 
[37179:37531]
Q5HJW6 Putative protein 3479–3709 37,637–37,867 231 Forward
COL, CP000046 [37550:37780] 
and MW2, BA000033 
[37629:37859]
dru SCC direct repeat units 3619–4056 37,777–38,214 438 COL, CP000046 [37690:38127]
ugpQ Glycerophosphoryl diester phosphodiesterase 4258–5001 38,416–39,159 744 Forward
COL, CP000046 [38329:39072] 
and MW2, BA000033 
[38288:39031]
ydeM Putative dehydratase 5098–5526 39,256–39,684 429 Forward
COL, CP000046 [39169:39597] 
and MW2, BA000033 
[39128:39556]
txbi_mecA Bidirectional rho-independent terminator of mecA 5517–5581 39,675–39,739 65
mecA Penicillin binding protein 2a 5572–7578 39,730–41,736 2007 Reverse MW2, BA000033.2 [39602:41608]
mecR1-trunc
Methicillin resistance operon 
repressor 1, truncated as in 
SCCmec I, IV, V
7678–8652 41,836–42,810 975 Forward (trunc.)
hsdR2-IS1272
Fragment of type I restriction-
modification system endonu-
clease
8653–8886 42,811–43,044 234 Truncated
COL, CP000046 [42724:42957] 
and MW2, BA000033 
[42683:42916]
tnpIS1272 Transposase for IS1272 8887–10,410 43,045–44,568 1524 Reverse
COL, CP000046 [42958:44481] 
and MW2, BA000033 
[42917:44440]
Q9KX75 Putative protein 10,546–11,052 44,704–45,210 507 Reverse
Q7A207 Putative protein 11,068–11,379 45,226–45,537 312 Reverse 06BA18369, ARXY01000001 [134883:135194]
Q7A206 Putative protein 11,466–11,816 45,624–45,974 351 Reverse 06BA18369, ARXY01000001 [135281:135631]
ccrB-1 Cassette chromosome recombi-nase B, type 1 12,282–13,907 46,440–48,065 1626 Reverse
ccrA-1 Cassette chromosome recombi-nase A, type 1 13,929–15,278 48,087–49,436 1350 Reverse
06BA18369, ARXY01000001 
[137744:139093]
cch-1 Cassette chromosome helicase 15,466–17,235 49,624–51,393 1770 Reverse CMFT532, HF569114 [8453:10222]
DUF1413-06BA18369 Putative protein associated with cch 17,235–17,525 51,393–51,683 291 Reverse
06BA18369, ARXY01000001 
[141050:141340]
Q83ZD5 Putative protein 17,696–18,769 51,854–52,927 1074 Forward 06BA18369, ARXY01000001 [141511:142584]
Helicase M06 DEAD/DEAH box helicase domain protein 18,863–20,803 53,021–54,961 1941 Forward
06BA18369, ARXY01000001 
[142678:144618]
Q6GD51 Putative protein 21,060–21,368 55,218–55,526 309 Forward 06BA18369, ARXY01000001 [144875:145183]
D3QFP0-SCC Putative lipase/protease 21,415–21,653 55,573–55,811 239 Reverse (trunc.)
06BA18369, ARXY01000001 
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CC1153-MRSA were mostly identified in Kuwait and the UAE. The clear majority, i.e. all isolates except 
the oldest  one33, harboured SCCmec/SCCfus chimeric elements and the most common variant that could be 
described either as SCCmec I + fusC element or as a pseudoSCCmec class B + fusC + ccrA/B-1 element was 
sequenced. Sequence analysis also revealed (see above and Table 1) that ccrB-1 and accompanying genes are 
more related to alleles from other SCCfus elements rather than to the ones from SCCmec. Thus, a description 
as a pseudoSCCmec class B + ccrA/B-1 + fusC element should be regarded as the correct one. The mec complex 
B could have been derived from either a SCCmec I or SCCmec IV element. However, the latter one was more 
probable based on of the MW2-like allele of mecA.
The entire region associated with fusC (encompassing Q7A207, Q7A206, ccrB-1, ccrA-1, cch-1, DUF1413, 
Q83ZD5, helicase M06, Q6GD51, D3QFP0-SCC, D3JCW9, fusC, tnpIS150, tnp_A8YYY6, Q4LAG7-SCCfus and 
yobV) could be seen as one mobile genetic element that got introduced into a CC1153-MRSA replacing Q7A207, 
Q7A206 and the ccr recombinase genes that previously belonged to its SCCmec element. This set of genes was also 
Table 1.  The SCCmec/SCCfus composite element in M58.
Gene ID Explanation Position in SCC (nt) Position in genome (nt) Length (nt) Direction Sequence identical to
D3JCW9 Putative protein 21,478–21,636 55,636–55,794 159 Forward
06BA18369, ARXY01000001 
[145293:145451] and MSSA476, 
BX571857 [52344:52502]
fusC Fusidic acid resistance protein C 21,954–22,592 56,112–56,750 639 Forward
06BA18369, ARXY01000001 
[145769:146407] and MSSA476, 
BX571857 [52820:53458]
tnpIS150 Transposase of IS150 23,068–23,382 57,226–57,540 315 Forward CMFT463, HF569110 [16043:16357]
tnp A8YYY6 Transposase 23,394–24,209 57,552–58,367 816 Forward (trunc.)
Q4LAG7-SCCfus Putative protein 24,356–24,784 58,514–58,942 429 Reverse 06BA18369, ARXY01000001 [148171:148599]
yobV Transcriptional regulator 24,864–25,793 59,022–59,951 930 Forward 06BA18369, ARXY01000001 [148679:149608]
DR_SCC Direct repeat of SCC 25,890–25,908 60,048–60,066 19
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found in a Staphylococcus hominis subsp. hominis strain and a CC5-MSSA from Canada (06BA18369 GenBank 
ARXY00000000.1) as described above. Furthermore, MRSA strains from Saudi  Arabia25 (as represented by iso-
lates CMFT492, HF569112.1 and CMFT532, GenBank HF569114.1; see Tables 2, 3, 4 and 5) also carried the same 
region associated with fusC (differing from the one in M58 only in minor random deletions) as part of complex 
chimeric SCCmec II elements. In CMFT492, this cluster was inserted between orfX and a truncated SCCmec 
II element that lacked the kdp locus, cstA/B/R and the transposons introducing ble/aadD and erm(A)/ant9. In 
CMFT532 and other strains (see Tables 2, 3, 4 and 5), the region associated with fusC was inserted between 
orfX and a normal SCCmec II element. In these strains, additional markers (sccterm13, Q8CU82, tarF-SCC, 
A9UFT0, Q9KX75) were also associated with the fusC element that were absent in M58. Furthermore, there were 
also strains such as FORC 090, GenBank CP029198.1 or AR466, CP029080.1 in which fusC and its immediate 
neighbours (Q83ZD5, helicase M06, Q6GD51, D3QFP0-SCC, D3JCW9, tnpIS150, tnp A8YYY6, Q4LAG7-
SCCfus and yobV) were accompanied by other ccr recombinase genes and other genes upstream, towards orfX. 
This prompted us to review published sequences and to compare them with the CC1153 strain described herein 
to sort and to classify the different gene clusters accompanying fusC.    
Review of fusC elements. When comparing the region around fusC from M58 to published sequences, it 
became obvious that 64 published S. aureus sequences (plus three S. hominis sequences and nine un-assembled 
S. aureus sequences from the Short Read Archive) cluster into 31 different SCCfus or SCCmec/fusC chimeric 
or composite elements (Tables 2, 3, 4, 5/Supplemental File 5). None of these fully matched the M58 sequence. 
When considering only the immediate region around fusC, strains were identified in which the same gene clus-
ter as M58 was present and it was observed that there are only four, possibly five, different sets of genes directly 
accompanying this resistance gene (Tables 2, 3, 4, 5/Supplemental File 5 and Fig. 2).
These sets could be regarded as fixed gene complexes in analogy to the mec complexes A (in SCCmec II 
and III), B (in SCCmec I and IV) and C (in SCCmec V). Likewise, they are also associated with different sets of 
SCC-recombinase genes including alleles of ccrA-1/ccrB-1, ccrA-1/ccrB-3, ccrA-3/ccrB-3, ccrA-4/ccrB-4, ccrA/
ccrB1 (FORC_90) and ccrAA/ccrC. Resulting “SCCfus” elements can, besides fusC-complexes and recombinase 
genes, also carry additional payload including tarF (teichoic acid biosynthesis protein F), speG (spermidine 
N-acetyltransferase), various variants of type I restriction-modification systems or mec complexes. They also can 
be linked to entire SCCmec elements resulting in complex genomic islands sometimes even including multiple 
sets of recombinase genes. These additional components can be localized upstream (towards orfX) or downstream 
(see Tables 2, 3, 4, 5/Supplemental File 5).
The longest known of the fusC-complexes (“A”, Table 2, see also Supplemental File 5 and Fig. 2), as in 
MSSA476, BX571857.1, comprises Q6GD54 (putative protein), Q6GD53 (putative protein), tirS (staphylococcal 
Toll/interleukin-1 receptor domain mimic), Q6GD51, D3QFP0-SCC, D3JCW9, fusC, sccterm03, Q6GD49 (puta-
tive protein), Q8CU43 (putative protein), Q4LAG7-SCCfus and yobV (for explanations and GenBank entries 
of the genes discussed, see Supplemental File 4). It can be found in MSSA, such as the prototypical CC1-MSSA 
sequence Sanger MSSA476, as well as in MRSA. It appears in MRSA strains (CC1 and CC5) with SCCmec IV 
elements, mainly form the Middle  East25, 28, 30, 31, Australia and New  Zealand38 as well as in SCCmec V strains 
from the Middle East.
A second fusC-complex (“B”, Table 3, see also Supplemental File 5 and Fig. 2) comprises Q6GD54, Q6GD53, 
tirS, Q6GD51, D3QFP0-SCC, D3JCW9 and fusC. Besides gene content, it also differs from all others in five char-
acteristic single nucleotide polymorphisms (SNP) within the fusC gene (14A > C; 150T > G; 290G > C; 537A > T; 
632T > C). This complex has apparently not yet been observed in MSSA but there are several MRSA strains har-
bouring it connected to various SCCmec elements. One is HDE288, as prototypical sequence the “New Paediatric” 
CC5-MRSA strain from  Portugal47. Here, the fusC-complex is accompanied by ccrA/B-4 genes and a mec complex 
B, a combination also referred to as SCCmec VI. Another CC5 (ST149) strain, known from  Malta48, the Middle 
 East14, 25 and  UK26 harbours the same fusC-complex, together with ccrA/B-3 alleles and a SCCmec IV element. It 
also appears, although Q6GD54 is absent, in a SCCmec I MRSA strain from France (CC5, “Geraldine Clone”49).
A third fusC-complex (“C”, Table 4, see also Supplemental File 5 and Fig. 2) consisting of Q83ZD5, helicase 
M06, Q6GD51, D3QFP0-SCC, D3JCW9, fusC, tnpIS150, tnp A8YYY6, Q4LAG7-SCCfus and yobV. The fusC 
sequence is identical to the one in MSSA476, BX571857.1. This is the variant found in M58 and the other 
strains discussed above. In these strains, it is accompanied by a largely identical set of recombinase-associated 
genes. The carriage of sccterm13, Q8CU82, tarF-SCC, A9UFT0, Q9KX75 as additional payload is variable; in 
M58 these genes are replaced by the mec complex, while in the CMFT492, CMFT535 etc., the SCCmec ele-
ment is located downstream away from orfX25. Strains FORC090 (CP029198.1), AR466 (CP029080.1), MRSA18 
(SAMEA1317993)26 and 20121643 (ERR1595888/SAMEA3924203) harbour the same fusC-complex but in these 
sequences, it is accompanied by other recombinase alleles.
A fourth fusC-complex (“D1”, Table 5, see also Supplemental File 5 and Fig. 2) consists of Helicase M06, 
Q6GD51, D3QFP0-SCC, D3JCW9, fusC, sccterm03, Q6GD49, Q8CU43, Q4LAG7S-SCCfus and yobV. Its fusC 
gene has one characteristic SNP (309G > A). It was not yet found in MSSA, but in MRSA belonging to CC8, CC30 
and  ST83430. In these strains, it is accompanied by a mec complex B and a set of ccrA/B-4 genes. It has been found 
neither in any other context, nor in MSSA strains.
A CC15 SCCmec V MRSA strain harbours a fusC-complex consisting of helicase M06, Q6GD51, D3QFP0-
SCC, D3JCW9, fusC, sccterm03, Q6GD49 and Q8CU43. The fusC sequences contain a specific SNP (486T > C), 
but otherwise, gene content (apart from the lack of Q4LAG7-SCCfus and yobV) and the order of genes are the 
same as in the fourth complex (hence, “D2”, Table 5, see also Supplemental File 5 and Fig. 2). The fusC-complex 
itself is in all these sequences localised on one contig, but other associated markers such as SCCmec, orfX etc. are 
split across several contigs. One ST72 sequence (HST-084, AZTF00000000.1) has a SCCmecV/SCCfus chimeric 
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Table 2.  Staphylococcal Cassette Chromosomes with a fusC-associated complex A consisting of Q6GD54, 
Q6GD5, tirS, Q6GD51, D3QFP0-SCC, D3JCW9, fusC, sccterm03, Q6GD49, Q8CU43, Q4LAG7-SCCfus 
and yobV. Please note that this is an abridged version (with genes encoding “putative proteins” omitted); for a 
more detailed version, see Supplement 5. References25, 26, 35, 38–46. *Variably present in different sequences of the 
respective type. **Split across two or more contigs so that the correct order of SCC elements and/or individual 
genes cannot be determined.
Page 2
Reference Sequence: Strain 
(Clonal Complex), GenBank 
accession








Other SCC markers 
downstream/away from 
orfX
Other genome sequences 
harbouring the same SCCfus
element
Other references or descriptions and 
geographic background
MSSA476 (CC1), BX571857.1 sccterm06 (terminus of SCC towards 
orfX), hsdR (type I restriction-
modification system, TIRMS, 
endonuclease), hsdS (TIRMS site-
specificity determinant), hsdM (TIRMS 
DNA methylase)
ccrB-1, ccrA-1 A N/A FORC_026 (CC1), CP013132.1; 
FORC_045 (CC1), CP017115.1;
FDAARGOS_2 (CC1), CP026964.1; 
PMB 81-4 (CC1), CP034441.1; 
KT/314250 (CC1), AOCP; 
MUF256, AZSE;
Strain 21304, JHPW; 
ST20110167 (CC1), FSSD;
3 (B) GCID_STAPE_0004, SUKH; 
23 GCID_STAPE_0022, SUKK;
43 GCID_STAPE_0029, SUKO; 
3 (A) GCID_STAPE_0003, SUKX;
6 (A) GCID_STAPE_0004, SUKY
CC1-MSSA from France 35, India 40;
Malaysia 41, South Korea, UK 42, and the 
USA (?) 
Bovine CC1-MSSA from South Korea
Note: this corresponds to “SCC476” 26.
WMCS6087, JBHR sccterm06, hsdR3, hsdS3, hsdM3 ccrB-1, ccrA-1 A** SCCmec II N/A Isolate from the USA
Strain 515798 (CC1), CP045474.1 SCCmec IV a, 
sccterm06, hsdR3, hsdS3, hsdM3
ccrB-1, ccrA-1 A N/A N/A MRSA 2,3, 6, 14, 22 from UK 26;
CC1-MRSA from UAE 39,43,44
Note: this corresponds to “SCC476 and 
SCCmec IVa” and “SCCmec-fus I” 26.
NZAK3 (CC5), LT009690.1 SCCmec IV a N/A A N/A N/A CC5-MRSA from New Zealand 38;
MRSA 10 (CC5) from UK 26




SCCmec V ccrB-1, ccrA-1 A N/A N/A CC1-MRSA from France 35
MUM475 (CC1), AZSG** SCCmec VT, 
sccterm06*, hsdR3, hsdS3, hsdM3
ccrB-1, ccrA-1 A N/A MRSA1_ST20130096 (CC1), FSRY CC1-MRSA from India 40;
CC1-MRSA from France 35




sccterm07, hsdR, hsdS, speG ccrB-1, ccrA-1 A SCCmec III N/A CC239-MRSA from Taiwan 46
45394F, GU122149.1 sccterm07, hsdR, hsdS, speG ccrB-1, ccrA-1 A SCCmec IV N/A MRSA from the Netherlands (?)
MSSA 199 (CC8), CP031667.1 dcs-trnc., sccterm07, hsdR-trnc., hsdS ccrB-3, ccrA-1 A N/A MSSA 64 (CC8), CP031670.1; 
UP_1591 (CC8), CP047809.1; 
ST20121341 (CC8), FSSE
CC8-MSSA from Germany; 
CC8-MSSA from France 35
CMFT535 (CC22), HF569115.1 sccterm07, hsdR-trnc., hsdS ccrB-3, ccrA-1 A SCCmec IV CMFT201 (CC22), HF569098.1; 
CMFT303 (CC22), HF569103.1; 
CMFT306 (CC22), HF569104.1
CC22-MRSA from Saudi Arabia 25
*variably present in different sequences of the respective type,   **split across two or more contigs so that the correct order of SCC elements and/or individual genes cannot be determined
Table 3.  Staphylococcal Cassette Chromosomes with a fusC-associated complex B consisting of Q6GD54, 
Q6GD53, tirS, Q6GD51, D3QFP0-SCC, D3JCW9 and fusC (14A > C; 150 T > G; 290G > C; 537A > T; 
632 T > C). Please note that this is an abridged version; for a more detailed version, see Supplement 5. 
References14, 25, 26, 35, 47–51.
Reference Sequence: Strain 
(Clonal Complex), GenBank 
accession








Other SCC markers 
downstream/away from 
orfX
Other genome sequences 
harbouring the same SCCfus
element
Other references or descriptions and 
geographic background
CMFT3002 (CC5), HF569102.1 sccterm14, yeeA (putative DNA 
methyltransferase) 
ccrB-3, ccrA-3 B SCCmec IV CMFT106 (CC5), HF569093.1; 
CMFT181 (CC5), HF569097.1; 
SAMEA2042721
Maltese CC5 isolates 48;
CC5-MRSA from Saudi Arabia 14,25 ;
MRSA 1, 4, 5,13, 15, 17 from UK 26.
Note: this corresponds to “SCCmec IVa
and SCC149”. 
26.
ERS1461791/DSM 28763 (CC8), 
LT671859.1
SCCmec IV N/A B N/A
(in CC45 sequences, a 
CC45 specific genomic 
island is directly adjacent: 






CC8-MRSA from Germany 
(LT671859.1), 
CC5-MRSA from France 35
MRSA8, 9, 11, 12, 16, 19, 20, 21, 23 
(CC45) from UK 26
Probably (based on array profile) an 
epidemic CC22-MRSA from Germany 
50




SCCmec IV N/A B hsdM/hsdS/hsdR and the 
CC45- specific genomic 
island 
N/A CC45-MRSA from Germany
HDE288 (CC5), AF411935.3 [mec complex B] ccrB-4, ccrA-4 B N/A FDAARGOS_48 (CC5), CP026953.1; 
FDAARGOS_1 (CC5), CP026968.1; 
091751_57, GenBank AHZH/
SAMN02470727
CC5-MRSA from Portugal 39,55; MRSA 
from Switzerland; 
UK-EMRSA-12 and -13 (CC8) from 
UK
NCTC13140 (CC8), LS483319.1 [mec complex B] ccrB-4, ccrA-4 B N/A N/A CC8-MRSA from UK
HT20030749 (CC5), FSRX SCCmec I with an integrated plasmid 
harbouring aadD and ble
N/A B hsdR, hsdM SAMEA2664142 (CC5) Geraldine Clone from France 35,49;
MRSA 7 from UK 26
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element harbouring Helicase M06, Q6GD51, D3QFP0-SCC, D3JCW9 and a fusC gene with the same (486T > C) 
SNP but unfortunately, it is fragmented across several contigs. Another strain (ER03364.3, CP030550.1) with a 
SCCmecVT/SCCfus chimeric element also harbours helicase M06, Q6GD51, D3QFP0-SCC, D3JCW9 and fusC. 
However, the identity of fusC with the one in MSSA476, BX571857.1 (i.e., the absence of the 309G > ASNP) sug-
gests it to be derived from the third fusC-complex (Table 4, see also Supplemental File 5).
Further investigations on fusC-complexes associated with SCCmec V/VT are warranted as such isolates from 
diverse clonal complexes including CC5, CC97, CC121 and CC1153 (see above) have been observed, especially 
in the Arabian Gulf region.
Finally, truncated fusC-complexes were also observed as part of a very complex composite SCCmec element 
in a CC779 isolate M06/0171, HE980450.152 and of a composite “pseudo-SCC” element (i.e., without ccr genes) 
in Staphylococcus hominis subsp. hominis TFGsh5-1, AB930128.1. As the third and the fourth complex, it encom-
passes genes for helicase M06, Q6GD51, D3QFP0-SCC, D3JCW9 and fusC; but its fusC allele indicates relation 
to the third one (Table 4, see also Supplemental File 5).
Table 4.  Staphylococcal Cassette Chromosomes with a fusC-associated complex C consisting of Q83ZD5, 
helicase M06, Q6GD51, D3QFP0-SCC, D3JCW9, fusC, tnpIS150, tnp A8YYY6, Q4LAG7-SCCfus and yobV. 
Please note that this is an abridged version; for a more detailed version, see Supplement 5. References25, 26, 45, 52, 53. 
**Split across two or more contigs so that the correct order of SCC elements and/or individual genes cannot be 
determined.
Reference Sequence: Strain 
(Clonal Complex), GenBank 
accession








Other SCC markers 
downstream/away from 
orfX
Other genome sequences 
harbouring the same SCCfus
element
Other references or descriptions and 
geographic background
06BA18369 (CC5), ARXY sccterm13, tarF-SCC ccrB-1, ccrA-1 C N/A Staphylococcus hominis subsp. 
hominis NTUH-339, GenBank 
KY643657.1
CC5-MSSA from northern 
Saskatchewan, Canada 53
S. hominis subsp. hominis from Taiwan




CMFT352 (CC30), HF569107.1; 
CMFT463 (CC30), HF569110.1;
CMFT489 (CC30), HF569111.1 
CC30-MRSA from Saudi Arabia 25
CMFT492 (CC30), HF569112 sccterm13, tarF-SCC ccrB-1, ccrA-1 C Truncated SCCmec II N/A CC30-MRSA from Saudi Arabia 25
M58 [mec complex B] ccrB-1, ccrA-1 C N/A N/A This paper
FORC 090 (CC5), CP029198.1 yeeA, transposase for IS256, nuclease, 
YeeC-like putative protein 
ccrB, ccrA C SCCmec II N/A South Korea
MRSA18 (CC8), SAMEA1317993 sccterm07, hsdR, hsdS, ccrB-4, ccrA-4,
mec complex B
ccrB-4, ccrA-4 C N/A N/A MRSA 18 from UK 26
St960 (CC22?), FGHB**/
SAMEA1317550
sccterm07, hsdR ccrB-4, ccrA-4 C SCCmec IV N/A CC22 (?, described as UK-EMRSA-15) 
from UK
AR466 (CC45), CP029080.1 sccterm07, hsdR, hsdS, ccrB-4, ccrA-4, 
thyA-pla, dfrA, IS431, mec complex B
ccrB-4, ccrA-4 C N/A N/A CC45-MRSA from the USA
Strain 20121643 (CC8),
ERR1595888/SAMEA3924203
sccterm07, hsdR, hsdS, ccrB-4, ccrA-4,
thyA-pla, dfrA, IS431, mec complex B
ccrB-4, ccrA-4 C nupC2-SCC, psuG-SCC, 
ccrA-4
N/A CC8-MRSA, no details specified, from 
“European Region”.
ER03364.3 (CC72), CP030550.1 SCCmec VT with integrated tetK N/A (Truncated C) N/A N/A CC72 MRSA from the USA
M06/0171 (CC779), HE980450.1 IS431, mec complex C, IS431 N/A (Truncated C) Copper resistance operon,
speG, ccrB-4, ccrA-4, 
ccrAA, ccrC, hsdR, cas
N/A CC779-MRSA from Ireland 52
TFGsh5-1 (S. hominis), 
AB930128.1
sccterm02, IS431 N/A (Truncated C) speG, arsenic resistance 
operon
N/A S. hominis subsp. hominis from 
Taiwan45
**split across two or more contigs so that the correct order of SCC elements and/or individual genes cannot be determined
Table 5.  Staphylococcal Cassette Chromosomes with a fusC-associated complex D consisting of Helicase 
M06, Q6GD51, D3QFP0-SCC, D3JCW9, fusC (309G > A), sccterm03, Q6GD49, Q8CU43, Q4LAG7-SCCfus 
and yobV (D1) or HelicaseM06, Q6GD51, D3QFP0-SCC, D3JCW9, fusC (486 T > C), sccterm03, Q6GD49, 
and Q8CU43 (D2). Please note that this is an abridged version; for a more detailed version, see Supplement 
5. References28, 30, 32, 34. **Split across two or more contigs so that the correct order of SCC elements and/or 
individual genes cannot be determined.
Reference Sequence: Strain 
(Clonal Complex), GenBank 
accession








Other SCC markers 
downstream/away from 
orfX
Other genome sequences harbouring 
the same SCCfus element
Other references or descriptions 
and geographic background




CC8-MRSA from Germany/Middle 
East 30;
CC30-MRSA from Kuwait, Saudi 
Arabia and UAE 30;
ST834-MRSA from Saudi Arabia 30
RUH-2 (CC15), 
MF185204.1 to -09.1**
sccterm10, F8WKF9, F8WKG0, 
ALS84360, Q7A213, IS431 **






Human and livestock CC15 MRSA 
from Saudi Arabia 28,34;
CC15-MRSA from Kuwait 32
Livestock CC15 MRSA from Egypt 
(author´s unpublished observation)
HST-084 (CC72), AZTF (SCCmec V)** ** (Truncated D2) ccrAA N/A CC72 MRSA from Lebanon
**split across two or more contigs so that the correct order of SCC elements and/or individual genes cannot be determined
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There was no obvious phenotypical correlation of fusC-complexes to fusidic acid MICs, all tested strains 
(Supplemental File 6) were highly resistant regardless of their actual type of fusC-complex.
Further open questions are the timeframe of the evolution of SCCfus elements as well as their geographi-
cal origins. A wide variety of fusC-positive strains has not yet been sequenced. It would be interesting to know 
whether additional elements exist, and whether there are MSSA strains harbouring those fusC-complexes yet 
observed in MRSA only. The origin and evolutionary history of tirS is another open question. This virulence 
 factor35 is present in two out of five fusC-complexes but to the best of our knowledge, it has never been observed 
in another context.
As previously  discussed30, fusC was detected in as much as twenty-two different clonal complexes of S. aureus, 
CC1, CC5, CC6, CC7, CC8, CC15, CC22, CC30, CC45 [agr I], CC45 [agr IV], CC50, CC59, ST72, CC88, CC97, 
CC121, CC152, CC361, CC779, ST834, CC913 and CC1153 from essentially all parts of the world. This and 
the emergence of fusC-MRSA especially in the Middle East indicate a selective advantage associated with its 
presence. Fusidic acid can be administered intravenously, but this is not commonly done, and the intravenous 
formulation is not available everywhere. It is also used topically, as ointment for presumably staphylococcal skin 
conditions. Observations from New Zealand suggest a quick emergence of fusC-positive S. aureus in parallel to 
an increasing use of this  compound16, 38. A co-evolution of SCCmec and SCCfus elements might result in a public 
health hazard, as strains with composite or chimeric elements are selected for both, in the hospital by beta-lactam 
administration as well as in the community by topical use of fusidic acid. Thus, antibiotic stewardship and infec-
tion control measures targeting MRSA in the hospital must be accompanied by restrictions to an uncontrolled 
over-the-counter sale of fusidic acid in outpatient settings as well as by a prudent use in outpatient settings.
Materials and methods
Isolates. A list of the isolates studied is provided in Supplement 1. Isolates were selected out of various typ-
ing and epidemiological projects based on array hybridisation profiles indicative for an affiliation to CC1153.
The CC1153-MRSA from the UAE were isolated from skin and wound infections. The CC1153-MRSA from 
Saudi Arabia also originated from a wound infection. One CC1153-MSSA from Saudi Arabia was a nasal colo-
nizer from a healthcare worker, the others originated from skin and soft tissue infections (with three of them 
being identified during an earlier  study54). The first CC1153-MRSA reported in Kuwait was cultured from a 
wound inflicted by a dog bite in  200933. The other isolates were obtained between 2017 and 2020 mostly from 
wound infections of patients located in six hospitals. One isolate was isolated from a gynaecological swab, one 
from a nasal swab and one was obtained from blood culture. Egyptian isolates were identified from rural small-
holder dairy cattle that showed sub-clinical mastitis, i.e., somatic cell counts > 200,000 cell/mL and positive 
results of California Mastitis Test. The isolates were collected from six different cows in a herd, consisting of 25 
crossbred dairy cows, located at Dakahlia Governorate in the northeast of Cairo, Egypt. The milking procedure 
was performed manually in the examined cows, while the medical records of the farm revealed the usage of a 
wide spectrum of antibacterial  agents37. French isolates (11 MSSA, 1 MRSA) had been isolated during infections 
(cutaneous (n = 8), respiratory (n = 3), blood culture (n = 1)) in ten different hospitals between 2010 and 2017. 
One German MRSA isolate was cultured from an abscess of an approximately half year-old Egyptian child whose 
family lives in Germany. One German MSSA isolate originated from an abscess.
PVL detection was performed on six isolates by an experimental lateral flow  test54. Fusidic acid MICs were 
determined by agar gradient dilution tests with commercially available strips (01B10122 Fusidinsäure MIC Test 
Strip 0.016—256 µg/mL, Bestbion dx GmbH, Cologne, Germany).
Microarray‑based molecular characterization. Genotyping of all strains was performed using the S. 
aureus Genotyping Kit 2.0 system (Abbott [Alere Technologies GmbH, Jena, Germany]) microarray-based assay. 
The array covers 333 different targets related to approximately 170 different genes and their allelic variants. The 
list of target genes as well as sequences of probes and primers have previously been published along all relevant 
 protocols9, 39, 55.
Staphylococcus aureus was cultivated on Colombia blood agar. The DNA extraction was performed using 
lytic enzymes (lysostaphin, lysozyme, RNAse) and buffer from the S. aureus Genotyping Kit 2.0 kit and Qiagen 
DNA extraction columns (Qiagen, Hilden, Germany) according to manufacturers’ instructions. Then, a linear 
amplification was performed using one primer for each target sequence. During the linear multiplex-amplifi-
cation, biotin-16-dUTP was incorporated into the amplicons, which were then stringently hybridised to the 
specific probes on the microarray. After washing steps, hybridisation was detected using streptavidin horserad-
ish peroxidase that triggered local precipitation at those spots where amplicon was bound. Microarrays were 
photographed and analysed with a designated reader and software (IconoClust, Abbott [Alere Technologies]). 
Analysis allowed detecting presence or absence of certain genes or alleles, as well as assignment to the clonal 
complex, strains, and SCCmec types.
Whole‑genome sequencing. Genomic DNA was isolated from an overnight culture grown at 37  °C 
on Columbia blood agar using a Macherey and Nagel NucleoSpin Microbial DNA kit (MACHEREY–NAGEL 
GmbH & Co. KG, Dueren, Germany).
The Nanopore Oxford MinION platform was used for sequencing the whole genome of the CC1153 isolate 
M58 from the UAE. Briefly, size selection was performed using AMPure beads in a ratio 1:1 (v/v) with the DNA 
sample. The DNA library was generated using the nanopore sequencing kit SQK-LSK109 and the native bar-
coding expansion kit EXP-NBD103 (Oxford Nanopore Technologies, Oxford, UK) according to manufacturer’s 
instructions. The used flowcell FLO-MIN106 (R9-Version) was primed by the flow cell priming kit EXP-FLP001 
(Oxford Nanopore, Oxford, UK). The protocol named “1D Native barcoding genomic DNA” was used in version 
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NBE_9065_v109_revB_23May2018 (Last update: 03/09/2018). The guppy basecaller (v4.4.2., Oxford Nanopore 
Technologies, Oxford, UK) translated and trimmed the MinION raw data (fast5) into quality tagged sequence 
reads (4000 reads per fastq-file). Flye (v2.8.1) was used to assemble all reads to one large contig. Then, a racon-
medaka (racon v1.4.3; medaka v1.2.0) pipeline was applied for polishing (with settings and descriptions being 
provided as Supplement 7).
The genome sequence is provided under GenBank accession number CP065857.1.
Phylogenetic analysis. A panel of 154 non-motile, core genomic markers was selected. Inclusion criteria 
were presence in all S. aureus clonal complexes analysed as well as uniform length in all genomes. The used genes 
as well as the genome sequences considered are listed in Supplemental File 3. Sequences were concatenated and 
analysed using SplitsTree 4.056 using default settings (Supplemental File 3).
Received: 25 September 2020; Accepted: 12 March 2021
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